CNSX:IMCC

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

IM Cannabis Corp. focuses on breeding, growing, and supply of medical cannabis products in Israel and Germany. More Details


Snowflake Analysis

Adequate balance sheet with limited growth.

Share Price & News

How has IM Cannabis's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: IMCC is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: IMCC's weekly volatility has decreased from 18% to 11% over the past year.


Market Performance


7 Day Return

-4.7%

IMCC

3.0%

CA Pharmaceuticals

0.7%

CA Market


1 Year Return

390.0%

IMCC

49.4%

CA Pharmaceuticals

2.1%

CA Market

Return vs Industry: IMCC exceeded the Canadian Pharmaceuticals industry which returned 52.2% over the past year.

Return vs Market: IMCC exceeded the Canadian Market which returned 2% over the past year.


Shareholder returns

IMCCIndustryMarket
7 Day-4.7%3.0%0.7%
30 Day-2.0%32.8%4.6%
90 Day44.1%71.2%13.5%
1 Year390.0%390.0%49.4%49.4%5.8%2.1%
3 Yearn/a-51.7%-52.4%13.9%3.1%
5 Yearn/a413.7%410.0%67.3%41.6%

Long-Term Price Volatility Vs. Market

How volatile is IM Cannabis's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is IM Cannabis undervalued compared to its fair value and its price relative to the market?

13.8x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate IMCC's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate IMCC's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: IMCC is unprofitable, so we can't compare its PE Ratio to the CA Pharmaceuticals industry average.

PE vs Market: IMCC is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate IMCC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: IMCC is overvalued based on its PB Ratio (14.1x) compared to the CA Pharmaceuticals industry average (2.8x).


Next Steps

Future Growth

How is IM Cannabis forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

38.5%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if IMCC's forecast earnings growth is above the savings rate (1.5%).

Earnings vs Market: Insufficient data to determine if IMCC's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: IMCC's revenue (38.5% per year) is forecast to grow faster than the Canadian market (7.9% per year).

High Growth Revenue: IMCC's revenue (38.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if IMCC's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has IM Cannabis performed over the past 5 years?

14.4%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: IMCC is currently unprofitable.

Growing Profit Margin: IMCC is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if IMCC's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare IMCC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IMCC is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-61.1%).


Return on Equity

High ROE: IMCC has a negative Return on Equity (-23.33%), as it is currently unprofitable.


Next Steps

Financial Health

How is IM Cannabis's financial position?


Financial Position Analysis

Short Term Liabilities: IMCC's short term assets (CA$30.2M) exceed its short term liabilities (CA$4.0M).

Long Term Liabilities: IMCC's short term assets (CA$30.2M) exceed its long term liabilities (CA$5.4M).


Debt to Equity History and Analysis

Debt Level: IMCC is debt free.

Reducing Debt: IMCC had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IMCC has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: IMCC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 87.5% each year


Next Steps

Dividend

What is IM Cannabis's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate IMCC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate IMCC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if IMCC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IMCC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IMCC's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.0yrs

Average management tenure


CEO

Oren Shuster

1.25yrs

Tenure

Mr. Oren Shuster serves as the Co-owner of IMC Ltd. Mr. Shuster serves as Chief Executive Officer and Director of IM Cannabis Corp. since October 11, 2019.


Leadership Team

NamePositionTenureCompensationOwnership
Oren Shuster
CEO & Director1.25yrsno data22.83%
CA$ 91.3m
Shai Shemesh
Chief Financial Officerno datano data0.030%
CA$ 119.1k
Yaron Berger
Managing Director Israel Operation0.58yrno datano data
Yael Harrosh
Corporate Secretaryno datano datano data
Richard Balla
Chief Executive Officer of German Operation1yrno data0.13%
CA$ 525.0k

1.0yrs

Average Tenure

Experienced Management: IMCC's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Oren Shuster
CEO & Director1.25yrsno data22.83%
CA$ 91.3m
Steven Mintz
Director2.25yrsno data0.69%
CA$ 2.7m
Vivian Bercovici
Independent Director0.83yrno datano data
Marc Lustig
Independent Chairman2yrsno data0.85%
CA$ 3.4m
Rafael Gabay
Director0.83yrno data20.35%
CA$ 81.4m

1.3yrs

Average Tenure

Experienced Board: IMCC's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.8%.


Top Shareholders

Company Information

IM Cannabis Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: IM Cannabis Corp.
  • Ticker: IMCC
  • Exchange: CNSX
  • Founded: NaN
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CA$400.077m
  • Shares outstanding: 160.03m
  • Website: https://www.imcannabis.com

Number of Employees


Location

  • IM Cannabis Corp.
  • Kibbutz
  • Glil Yam
  • Tel Aviv
  • Israel

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IMCCCNSX (Canadian National Stock Exchange)YesCommon SharesCACADNov 2019
IMCN.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDNov 2019

Biography

IM Cannabis Corp. focuses on breeding, growing, and supply of medical cannabis products in Israel and Germany. Its products include strains and oils. The company also offers its intellectual property relat...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/22 00:19
End of Day Share Price2021/01/21 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.